CUAMC
CLSD

China Universal Asset Management Company’s Clearside Biomedical CLSD Stock Holding History

China Universal Asset Management Company’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-38
Closed -$1K – 410
2022
Q3 		$1K Buy
+38
New +$832 ﹤0.01% 388

Other funds holding CLSD

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

China Universal Asset Management Company's CLSD Position: Q4 2022 in Review

China Universal Asset Management Company sold out of Clearside Biomedical (CLSD) in Q4 2022, closing a stake of 38 shares — an estimated $1K sold.

China Universal Asset Management Company first reported a position in CLSD in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 53 funds tracked by Wall St. Rank hold CLSD as of Q4 2022.

  • China Universal Asset Management Company reported no remaining Clearside Biomedical position as of Q4 2022 after selling out during the quarter.
  • China Universal Asset Management Company sold 38 Clearside Biomedical shares in Q4 2022, an estimated $1K.
  • China Universal Asset Management Company first reported a position in Clearside Biomedical in Q3 2022 and held it in 1 quarter.
  • China Universal Asset Management Company's Clearside Biomedical position peaked at $1K in Q3 2022.
  • 53 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2022.

Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.